JI-101

    • Catalog No.:MC1381
      • CasNo:
      • 900573-88-8
      • MolecularFormula:
      • C22H20BrN5O2
      • Purity:
      • >98%
      • Target:
      • Ephrin Receptor 
      • IC50:
      • No data
      • Fields:
      • JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4). JI-101 inhibits angiogenesis, and subsequently tumor growth.
      • Specificity:
      • TargetTargets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4). JI-101 inhibits angiogenesis, and
      • Concentration:
      • >98%
      • Storage Stability:
      • 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO
      • Other Name:
      • JI101,JI 101
      • MolecularWeight(Da):
      • 466.33
      • References:
      • [1]. Mark L. Wade, Neeraj Agarwal et al. A pilot study of JI-101, an inhibitor of VEGFR-2, PDGFR-β, and EphB4 receptors, in combination with everolimus and as a single agent in an ovarian cancer expan
      • Products Images